RIOX2 and breast carcinoma: Altogether, our research on mdig provided a much-needed rationale to explore its activities in several aspects of inflammation, stemness, metabolism, cell growth, metastasis, and epigenetic reprogramming orchestrating the carcinogenesis machinery in breast cancer.